| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA Statement: Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
USA. FDA Statement: Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
(...) To encourage drug companies to enter the OTC market and increase access to naloxone, the FDA took an unprecedented step: we developed a model DFL with easy-to-understand pictograms on how to use the drug. We also conducted label comprehension testing to ensure the instructions were simple to follow. (FDA - U.S. Food and Drug Administration, 17.01.2019)
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm